New imide 5-HT1A receptor ligands - Modification of terminal fragment geometry

Molecules

Volumn 9, Issue 3, 2004, Pages 170-177

  Bojarski, Andrzej J ^a   Mokrosz, Maria J ^a   Duszyńska, Beata ^a   Kozioł, Aneta ^a   Bugno, Ryszard ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1,2,3,4 tetrahydroisoquinoline derivatives; 5 HT1A ligands; Arylpiperazine derivatives

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 1 (2 METHOXYPHENYL) 4 (4 SUCCINIMIDOBUTYL)PIPERAZINE; 1 (2 METHOXYPHENYL) 4 [4 (1,8 NAPHTHALIMIDO)BUTYL]PIPERAZINE; 1 (2 METHOXYPHENYL) 4 [4 (3 PHENYLMALEIMIDO)BUTYL]PIPERAZINE; 1 (2 METHOXYPHENYL) 4 [4 (3 PHENYLSUCCINIMIDO)BUTYL]PIPERAZINE; 4 [[[2 (1,2 CYCLOHEXANEDICARBOXYIMIDO)]BUTYL] 1 (2 METHOXYPHENYL)]PIPERAZINE; PIPERAZINE DERIVATIVE; RECEPTOR BLOCKING AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EVALUATION; GEOMETRY; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 3242754217     PISSN: 14203049     EISSN: None     Source Type: Journal    
DOI: 10.3390/90300170     Document Type: Article

References (17)

1. 1A Receptors. Curr. Med. Chem. 2002, 9, 443.
2. Goa, K.L.; Ward, A. Buspirone a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 1986, 32, 114.
3. Glennon, R.A.; Naiman, N.A.; Pierson, M.E.; Titeler, M.; Lyon, R.A.; Weisberg, E. NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH- DPAT). Eur. J. Pharmacol. 1988, 154, 339.
4. Zifa, E.; Fillion, G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 1992, 44, 401.
5. 1A Receptors. Med. Chem. Res. 1994, 4, 161.
6. 1A Receptor Antagonists. Eur. J. Med. Chem. 2002, 37, 273.
7. 1A Receptor Antagonist with Anxiolytic-Like Activity, in Mice and Rats. J. Pharm. Pharmacol. 2003, 55, 533.
8. 1A Receptor Antagonists in Three Rat Models of Anxiety. Neuropharmacology 2000, 39, 1848.
9. 1A Receptor Ligand with the Same Activity Profile as Buspirone. J. Med. Chem. 1996, 39, 1125.
10. Deren-Wesolek, A.; Tatarczynska, E.; Chojnacka-Wojcik, E. The novel buspirone analogue, 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl)[butyl]-8-azaspiro [4.5]decane-7,9-dione, with anxiolytic-like and antidepressant-like effects in rats. J. Psychopharmacol. 1998, 12, 380.
11. Paluchowska, M.H.; Mokrosz, M.J.; Bojarski, A.J.; Wesołowska, A.; Borycz, J.; Charakchieva-Minol, S.; Chojnacka-Wójcik, E. On the bioactive conformation of NAN-190 (1) and MP3022 (2), 5-HT(1A) receptor antagonists. J. Med. Chem. 1999, 42, 4952.
12. 1A Ligands. Pharmazie 1994, 49, 781.
13. 1A receptor ligands. Bioorg. Med. Chem. 1999, 7, 287.
14. Hackling, A.; Ghosh, R.; Perachon, S.; Mann, A.; Holtje, H.D.; Wermuth, C.G.; Schwartz, J.C.; Sippl, W.; Sokoloff, P.; Stark, H. N-(omega-(4-(2- methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands. J. Med. Chem. 2003, 46, 3883.
15. Glennon, R.A.; Naiman, N.A.; Pierson, M.E.; Smith, J.D.; Ismaiel, A.M.; Titeler, M.; Lyon, R.A. N-(phthalimidoalkyl) derivatives of serotonergic agents: a common interaction at 5-HT1A serotonin binding sites? J. Med. Chem. 1989, 32, 1921.
16. 2 Receptor Affinity of Some 2- and 3-Substituted 1,2,3,4-Tetrahydro-β-carbolines. Pharmazie 1993, 48, 289.
17. Cheng, Y.; Prusoff, W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099.